Editors' ChoiceFOCIS HIGHLIGHTS

The right angle on IL-2 therapy

See allHide authors and affiliations

Science Immunology  06 Apr 2018:
Vol. 3, Issue 22, eaat6418
DOI: 10.1126/sciimmunol.aat6418

You are currently viewing the abstract.

View Full Text

Abstract

Engineered cytokines are able to improve immunotherapy in mouse tumor models.

View Full Text